Reston, Va.-based QuadraMed Corporation is being acquired by Francisco Partners (San Francisco), a technology-focused private equity firm, in an all-cash deal valued at $126 million.
Under the terms of the agreement, Francisco Partners will acquire all of the outstanding shares of QuadraMed’s common stock for $8.50 per share in cash, and all outstanding shares of its Series A Cumulative Mandatory Convertible Preferred Stock for $13.7097 per share in cash.
QuadraMed expects shareholder approval in the first quarter of 2010.
